THERESA PRESCOTT: Open Payments
NPI 1457404576 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 22 payments from 8 companies in 2025. Trend: 2023 $574 · 2024 $387 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 6 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
| Tris Pharma Inc | 3 | $65 |
| Collegium Pharmaceutical, Inc. | 3 | $52 |
| Alkermes, Inc. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Corium, LLC | 2 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: Qelbree, CAPLYTA, Dyanavel XR, Jornay PM, ARISTADA, AUSTEDO XR, Azstarys, Auvelity.
Industry payments across FL — which companies pay providers there.
